16:07:23 EDT Thu 23 May 2024
Enter Symbol
or Name

Login ID:
Victory Square Technologies Inc
Symbol VST
Shares Issued 97,930,700
Close 2023-12-19 C$ 0.125
Market Cap C$ 12,241,338
Recent Sedar Documents

Victory Square's Hydreight adds semaglutide to offering

2023-12-20 10:31 ET - News Release

Mr. Shafin Tejani reports


Victory Square Technologies Inc. portfolio company Hydreight Technologies Inc., a mobile clinical network and medical platform that enables flexible, at-home medical services across 50 states in the United States, has provided an update -- health care providers and their patients now have access to semaglutide through the Hydreight platform.

Semaglutide injections are commonly used to treat Type 2 diabetes. It can also be used together with diet and exercise to help control blood sugar and has become popular to help with weight management. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist and is only available with a doctor prescription and needs to be injected on a regular basis.

According to Goldman Sachs, it is projected that, by 2030, the global market for anti-obesity medications (AOMs) could grow by more than 16 times to $100-billion. Based on current trends, over half of the global population will be overweight or obese by 2035, compared with 38 per cent in 2020, according to a World Obesity Atlas 2023 forecast.

Shane Madden, chief executive officer of Hydreight, commented: "This is a significant inflection point for Hydreight and a pivotal point for our business. We have seen huge demand in the United States for medications like semaglutide to help with weight management. Our revolutionary technology platform allows doctors and nurses to connect with patients and pharmacy networks to provide continuous care and improve patient outcomes. Adding access to semaglutide through our platform is the first step in our shift from preventative medicine to essential health care, and we are only just getting started."

Hydreight is revolutionizing mobile medicine by building the largest mobile clinical network in the United States, which operates in over 650 cities nationally. Currently, Hydreight is utilizing its proprietary platform and mobile network to provide end-to-end care and has built the only platform that can now host the provision of fully integrated approach to patient care, which includes, lab tests, doctor prescriptions, drug delivery, drug administering, patient monitoring and regular follow-ups across the United States.

Hydreight has a robust product offering and continues to add products to its legacy IV (intravenous) drip therapy solution. Over the last few months, Hydreight has added aesthetics and filler as well as NAD+ to its platform. Next year, Hydreight's platform plans to expand to accommodate lab testing and 12 blood tests that can be taken at home or office with the support of a nurse. All these products allow health care providers using the Hydreight platform to provide a higher level of medicine and provide a pathway to shift into medical essentials.

Victory Square will be hosting an end-of-year investor webinar with chief executive officer Shafin Diamond Tejani next week.

In this webinar, Victory Square will present and discuss:

  • Corporate update on Victory Square, business model and recent financials;
  • Notable portfolio highlights;
  • 2024 outlook;
  • Investor question-and-answer session.

Please see details for the webinar as follows.

Date:  Thursday, Dec. 28, 2023

Time:  12 p.m. PST to 1 p.m. PST (3 p.m. EST to 4 p.m. EST)

About Hydreight Technologies Inc.

Hydreight Technologies is building the largest mobile clinic network in the United States. Its proprietary, fully integrated platform hosts a network of nearly 3,000 nurses, over 100 doctors and a pharmacy network across 50 states. The platform includes a built-in, easy-to-use suite of fully integrated tools for accounting, documentation, sales, inventory, booking and managing patient data; this enables licensed health care professionals to provide services directly to patients at home, office or hotel. Hydreight empowers nurses, med spa technicians and other licensed health care professionals to deliver services independently, on their own terms, or to add mobile services to existing location-based operations. The Hydreight platform hosts a 503B pharmacy network servicing all 50 states and is closely affiliated with a U.S.-certified e-script and telemedicine provider network that provides services in over 650 cities and growing.

About Victory Square Technologies Inc.

Victory Square builds, acquires and invests in promising start-ups, then provides the senior leadership and resources needed for fast-track growth. Victory Square's sweet spot is cutting-edge tech that is shaping the fourth industrial revolution. Victory Square's corporate portfolio consists of more than 25 global companies using AI (artificial intelligence), VR/AR (virtual reality/augmented reality) and blockchain to disrupt sectors as diverse as fintech, insurance, health and gaming.

What Victory Square does differently for start-ups

Victory Square is not your ordinary investor. With real skin in the game, Victory Square is committed to ensuring each company in its portfolio succeeds. Victory Square's secret sauce starts with selecting start-ups that have real solutions, not just ideas. Victory Square pairs you with senior talent in product, engineering, customer acquisition and more. Then, Victory Square lets you do what you do best -- build, innovate and disrupt. In 24 to 36 months, you will scale and be ready to monetize.

What Victory Square does differently for investors

For investors, Victory Square offers a liquid way to invest in some of the world's most innovative early-stage technology companies without buying a venture fund that requires accredited investor status or multiyear commitments. It also can be purchased by non-accredited investors who are restricted from buying venture funds. Victory Square's portfolio provides a uniquely liquid and transparent way for investors to get access to the latest technologies and emerging global trends. It is an excellent way to diversify into early-stage venture.

Victory Square invests primarily in leading-edge technologies such as artificial intelligence (AI), machine learning (ML), digital health, blockchain, gaming and climate tech, which provide the potential for high growth and returns.

Victory Square integrates a strong ESG (environmental, social and corporate governance) component throughout its operations. Victory Square's portfolio highlights minority entrepreneurs, often overlooked by traditional investors, including many from developing countries. Victory Square is also dedicated to giving back to the communities in which it serves and operates. Victory Square's mandate is to assist organizations through its time, talent and treasure. Victory Square is committed to organizations that provide services in the youth, mental health, special need, sport, technology, education, marginalized group, first nation and accessibility sectors.

Victory Square is a publicly traded company headquartered in Vancouver, Canada, and listed on the Canadian Securities Exchange (VST), Frankfurt Stock Exchange (6F6) and the OTCQX (VSQTF).

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.